Summary
Mutations in γc, a shared receptor subunit for interleukin (IL)-2, IL-4, IL-7, IL-9, IL-15, and IL-21, lead to profound impairment in T-cell and natural killer (NK) cell development and are responsible for X-linked severe combined immunodeficiency disease (X-SCID). Considerable attention has been paid to how the lack of γc expression and signaling results in failed lymphocyte development. However, γc is also an essential ligand binding subunit for γc-dependent cytokine receptors. Molecular modeling in conjunction with site-directed mutagenesis of γc indicates that a common mechanism is responsible for the ability of γc to bind multiple cytokines. This notion is related to instances in which mutations in the extracytoplasmic region of γc resulted in X-SCID.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Takeshita, T., Asao, H., Ohtani, K., et al. (1992) Cloning of the y-chain of the human IL-2 receptor. Science 257, 379–382.
Kondo, M., Takeshita, T., Ishii, N., et al. (1993) Sharing of the interleukin-2 (IL-2) receptor y-chain between receptors for IL-2 and IL-4 [see comments]. Science 262, 1874–1877.
Russell, S. M., Keegan, A. D., Harada, N., et al. (1993) Interleukin-2 receptor y-chain: a functional component of the interleukin-4 receptor [see comments]. Science 262, 1880–1883.
Noguchi, M., Nakamura, Y., Russell, S. M., et al. (1993) Interleukin-2 receptor y-chain: a functional component of the interleukin-7 receptor. Science 262, 1877–1880.
Kondo, M., Takeshita, T., Higuchi, M., et al. (1994) Functional participation of the IL-2 receptor y-chain in IL-7 receptor complexes. Science 263, 1453–1454.
Kimura, Y., Takeshita, T., Kondo, M., et al. (1995) Sharing of the IL-2 receptor y-chain with the functional IL-9 receptor complex. Int. Immunol. 7, 115–120.
Giri, J. G., Anderson, D. M., Kumaki, S., Park, L. S., Grabstein, K. H., and Cosman, D. (1995) IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukoc. Biol. 57, 763–766.
Parrish-Novak, J., Dillon, S. R., Nelson, A., et al. (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408, 57–63.
Asao, H., Okuyama, C., Kumaki, S., et al. (2001) The common y-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167, 1–5.
Noguchi, M., Yi, H., Rosenblatt, H. M., et al. (1993) Interleukin-2 receptor y-chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147–157.
Puck, J. M., Deschenes, S. M., Porter, J. C., et al. (1993) The interleukin-2 receptor y-chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum. Mol. Genet. 2, 1099–1104.
Nakamura, Y., Russell, S. M., Mess, S. A., et al. (1994) Heterodimerization of the IL-2 receptor 13- and y-chain cytoplasmic domains is required for signalling. Nature 369, 330–333.
Nelson, B. H., Lord, J. D., and Greenberg, P. D. (1994) Cytoplasmic domains of the interleukin-2 receptor 13 and y chains mediate the signal for T-cell proliferation. Nature 369, 333–336.
He, Y. W. and Malek, T. R. (1998) The structure and function of ye-dependent cytokines and receptors: regulation of T lymphocyte development and homeostasis. Crit. Rev. Immunol. 18, 503–524.
Nelson, B. H. and Willerford, D. M. (1998) Biology of the interleukin-2 receptor. Adv. Immunol. 70, 1–81.
DiSanto, J. P., Certain, S., Wilson, A., et al. (1994) The murine interleukin-2 receptor y chain gene: organization, chromosomal localization and expression in the adult thymus. Eur. J. Immunol. 24, 3014–3018.
Henthorn, P. S., Somberg, R. L., Fimiani, V. M., Puck, J. M., Patterson, D. F., and Felsburg, P. J. (1994) IL-2R y-gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease. Genomics 23, 69–74.
Yoo, J., Stone, R. T., Solinas-Toldo, S., Fries, R., and Beattie, C. W. (1996) Cloning and chromosomal mapping of bovine interleukin-2 receptor y gene. DNA Cell Biol. 15, 453–459.
Wang, T. and Secombes, C. J. (2001) Cloning and expression of a putative common cytokine receptor y-chain (ye) gene in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol. 11, 233–244.
Malek, T. R., Furse, R. K., Fleming, M. L., Fadell, A. J., and He, Y. W. (1995) Biochemical identity and characterization of the mouse interleukin-2 receptor 13 and yc subunits. J. Interferon Cytokine Res. 15, 447–454.
Noguchi, M., Adelstein, S., Cao, X., and Leonard, W. J. (1993) Characterization of the human interleukin-2 receptor y-chain gene. J Biol Chem. 268, 13601–13608.
Balasubramanian, S., Chernov-Rogan, T., Davis, A. M., et al. (1995) Ligand binding kinetics of IL-2 and IL-15 to heteromers formed by extracellular domains of the three IL-2 receptor subunits. Int. Immunol. 7, 1839–1849.
Letzelter, F., Wang, Y., and Sebald, W. (1998) The interleukin-4 site-2 epitope determining binding of the common receptor y-chain. Eur. J. Biochem. 257, 11–20.
Baker, D. P., Whitty, A., Zafari, M. R., et al. (1998) The murine anti-human common y-chain monoclonal antibody PC.B8 blocks the second step in the formation of the intermediate affinity IL-2 receptor. Biochemistry 37, 14337–14349.
Voss, S. D., Leary, T. P., Sondel, P. M., and Robb, R. J. (1993) Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor y-chain. Proc. Natl. Acad. Sci. USA 90, 2428–2432.
Saragovi, H. and Malek, T. R. (1987) The murine interleukin 2 receptor. Irreversible cross-linking of radiolabeled interleukin 2 to high affinity interleukin 2 receptors reveals a noncovalently associated subunit. J. Immunol. 139, 1918–1926.
Giri, J. G., Ahdieh, M., Eisenman, J., et al. (1994) Utilization of the (3 and ychains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13, 2822–2830.
de Jong, J. L., Farner, N. L., Widmer, M. B., Giri, J. G., and Sondel, P. M. (1996) Interaction of IL-15 with the shared IL-2 receptor 13 and yc subunits. The IL-15/3/yc receptor-ligand complex is less stable than the IL-2/13/yc receptor-ligand complex. J. Immunol. 156, 1339–1348.
Zurawski, S. M., Vega, F. Jr., Doyle, E. L., et al. (1993) Definition and spatial location of mouse interleukin-2 residues that interact with its heterotrimeric receptor. EMBO J. 12, 5113–5119.
Zurawski, S. M. and Zurawski, G. (1988) Identification of three critical regions within mouse interleukin 2 by fine structural deletion analysis. EMBO J. 7, 1061–1069.
Buchli, P. and Ciardelli, T. (1993) Structural and biologic properties of a human aspartic acid-126 interleukin-2 analog. Arch. Biochem. Biophys. 307, 411–415.
Pettit, D. K., Bonnert, T. P., Eisenman, J., et al. (1997) Structure-function studies of interleukin 15 using site-specific mutagenesis, polyethylene glycol conjugation, and homology modeling. J. Biol. Chem. 272, 2312–2318.
Kruse, N., Tony, H. P., and Sebald, W. (1992) Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. EMBO J. 11, 3237–3244.
Kruse, N., Shen, B. J., Arnold, S., Tony, H. P., Muller, T., and Sebald, W. (1993) Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J. 12, 5121–5129.
Schnarr, B., Ezernieks, J., Sebald, W., and Duschl, A. (1997) IL-4 receptor complexes containing or lacking the yc chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. Int. Immunol. 9, 861–868.
Hage, T., Sebald, W., and Reinemer, P. (1999) Crystal structure of the interleukin-4/receptor a-chain complex reveals a mosaic binding interface. Cell 97, 271–281.
Wang, Y., Shen, B. J., and Sebald, W. (1997) A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor a-chain. Proc. Natl. Acad. Sci. USA 94, 1657–1662.
Cosenza, L., Rosenbach, A., White, J. V., Murphy, J. R., and Smith, T. (2000) Comparative model building of interleukin-7 using interleukin-4 as a template: a structural hypothesis that displays atypical surface chemistry in helix D important for receptor activation. Protein Sci. 9, 916–926.
Sugamura, K., Asao, H., Kondo, M., et al. (1995) The common y-chain for multiple cytokine receptors. Adv. Immunol. 59, 225–277.
Olosz, F. and Malek, T. R. (2000) Three loops of the common y-chain ectodomain required for the binding of interleukin-2 and interleukin-7. J. Biol. Chem. 275, 30100–30105.
Raskin, N., Jakubowski, A., Sizing, I. D., et al. (1998) Molecular mapping with functional antibodies localizes critical sites on the human IL receptor common gamma (yc) chain. J. Immunol. 161, 3474–3483.
He, Y. W., Adkins, B., Furse, R. K., and Malek, T. R. (1995) Expression and function of the gamma c subunit of the IL-2, IL-4, and IL-7 receptors. Distinct interaction of yc in the IL-4 receptor. J. Immunol. 154, 1596–1605.
Malek, T. R., Levy, R. B., Adkins, B., and He, Y. W. (1998) Monoclonal antibodies to the common gamma-chain as cytokine receptor antagonists in vivo: effect on intrathymic and intestinal intraepithelial T lymphocyte development. J. Leukoc. Biol. 63, 643–649.
Olosz, F. and Malek, T. R. (2002) Structural basis for binding multiple ligands by the common cytokine receptor y-chain. J. Biol. Chem. 277, 12047–12052.
Elkins, P. A., Christinger, H. W., Sandowski, Y., et al. (2000) Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor. Nat. Struct. Biol. 7, 808–815.
de Vos, A. M., Ultsch, M., and Kossiakoff, A. A. (1992) Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306–312.
Syed, R. S., Reid, S. W., Li, C., et al. (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395, 511–516.
Whitty, A., Raskin, N., Olson, D. L., et al. (1998) Interaction affinity between cytokine receptor components on the cell surface. Proc. Natl. Acad. Sci. USA 95, 13165–13170.
Damjanovich, S., Bene, L., Matko, J., et al. (1997) Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study. Proc. Natl. Acad. Sci. USA 94, 13134–13139.
Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., and Wilson, I. A. (1999) Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283, 987–990.
Remy, I., Wilson, I. A., and Michnick, S. W. (1999) Erythropoietin receptor activation by a ligand-induced conformation change. Science 283, 990–993.
Caravella, J. A., Lyne, P. D., and Richards, W. G. (1996) A partial model of the erythropoietin receptor complex. Proteins 24, 394–401.
Gustchina, A., Zdanov, A., Schalk-Hihi, C., and Wlodawer, A. (1995) A model of the complex between interleukin-4 and its receptors. Proteins 21, 140–148.
Rajotte, D., Cadieux, C., Haman, A., et al. (1997) Crucial role of the residue R280 at the F’-G’ loop of the human granulocyte/macrophage colony-stimulating factor receptor a-chain for ligand recognition. J. Exp. Med 185, 1939–1950.
Layton, J. E., Iaria, J., Smith, D. K., and Treutlein, H. R. (1997) Identification of a ligand-binding site on the granulocyte colony-stimulating factor receptor by molecular modeling and mutagenesis. J. Biol. Chem 272, 29735–29741.
Bamborough, P., Hedgecock, C. J., and Richards, W. G. (1994) The interleukin-2 and interleukin4 receptors studied by molecular modeling. Structure 2, 839–851.
Kroemer, R. T. and Richards, W. G. (1996) Homology modeling study of the human interleukin-7 receptor complex. Protein Eng. 9, 1135–1142.
Layton, J. E., Iaria, J., and Nicholson, S. E. (1997) Neutralising antibodies to the granulocyte colony-stimulating factor receptor recognise both the immunoglobulin-like domain and the cytokine receptor homologous domain. Growth Factors 14, 117–130.
Horsten, U., Muller-Newen, G., Gerhartz, C., et al. (1997) Molecular modeling-guided mutagene-sis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6),IL-6 receptor.gp130 complex. J. Biol. Chem. 272, 23748–23757.
Brandhuber, B. J., Boone, T., Kenney, W. C., and McKay, D. B. (1987) Three-dimensional structure of interleukin-2. Science 238, 1707–1709.
Wlodaver, A., Pavlovsky, A., and Gustchina, A. (1992) Crystal structure of human recombinant interleukin-4 at 2.25 A resolution. FEBS Lett. 309, 59–64.
Smith, L. J., Redfield, C., Boyd, J., et al. (1992) Human interleukin 4. The solution structure of a four-helix bundle protein. J. Mol. Biol. 224, 899–904.
Kroemer, R. T., Doughty, S. W., Robinson, A. J., and Richards, W. G. (1996) Prediction of the three-dimensional structure of human interleukin-7 by homology modeling. Protein Eng. 9, 493–498.
Barlow, P. N., Norman, D. G., Steinkasserer, A., et al. (1992) Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. Biochemistry 31, 3626–3634.
Barlow, P. N., Steinkasserer, A., Norman, D. G., et al. (1993) Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232, 268–284.
Imler, J. L., Miyajima, A., and Zurawski, G. (1992) Identification of three adjacent amino acids of interleukin-2 receptor beta chain which control the affinity and the specificity of the interaction with interleukin-2. EMBO J. 11, 2047–2053.
Zhang, J. L., Buehner, M., and Sebald, W. (2002) Functional epitope of common y chain for interleukin-4 binding. Eur. J. Biochem. 269, 1490–1499.
Clackson, T., Ultsch, M. H., Wells, J. A., and de Vos, A. M. (1998) Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. J. Mol. Biol. 277, 1111–1128.
Middleton, S. A., Johnson, D. L., Jin, R., et al. (1996) Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family. J. Biol. Chem. 271, 14045–14054.
Malek, T. R., Porter, B. O., and He, Y. W. (1999) Multiple yc-dependent cytokines regulate T-cell development. Immunol. Today 20, 71–76.
Bamborough, P., Grant, G. H., Hedgecock, C. J., West, S. P., and Richards, W. G. (1993) A computer model of the interleukin-4/receptor complex. Proteins 17, 11–19.
Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669–672.
Leonard, W. J. (2000) X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years. Mol. Med. Today 6, 403–407.
Puel, A. and Leonard, W. J. (2000) Mutations in the gene for the IL-7 receptor result in T(—)B(+) NK(+) severe combined immunodeficiency disease. Curr. Opin. Immunol. 12, 468–473.
Conley, M. E., Lavoie, A., Briggs, C., Brown, P., Guerra, C., and Puck, J. M. (1988) Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc. Natl. Acad. Sci. USA 85, 3090–3094.
DiSanto, J. P., Rieux-Laucat, F., Dautry-Varsat, A., Fischer, A., and de Saint Basile, G. (1994) Defective human interleukin 2 receptor y chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. Proc. Natl. Acad. Sci. USA 91, 9466–9470.
Sharfe, N., Shahar, M., and Roifman, C. M. (1997) An interleukin-2 receptor y chain mutation with normal thymus morphology. J. Clin. Invest. 100, 3036–3043.
Kumaki, S., Ishii, N., Minegishi, M., et al. (1999) Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency. Blood 93, 607–612.
Russell, S. M., Tayebi, N., Nakajima, H., et al. (1995) Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270, 797–800.
Cao, X., Shores, E. W., Hu-Li, J., et al. (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor y chain. Immunity 2, 223–238.
DiSanto, J. P., Muller, W., Guy-Grand, D., Fischer, A., and Rajewsky, K. (1995) Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor y chain. Proc. Natl. Acad. Sci. USA 92, 377–381.
Nosaka, T., van Deursen, J. M., Tripp, R. A., et al. (1995) Defective lymphoid development in mice lacking Jak3. Science 270, 800–802.
Park, S. Y., Saijo, K., Takahashi, T., et al. (1995) Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3, 771–782.
Suzuki, K., Nakajima, H., Saito, Y., Saito, T., Leonard, W. J., and Iwamoto, I. (2000) Janus kinase 3 (Jak3) is essential for common cytokine receptor y chain (yc)-dependent signaling: comparative analysis of yc, Jak3, and yc and Jak3 double-deficient mice. Int. Immunol. 12, 123–132.
He, Y. W., Levy, R. B., and Malek, T. R. (1995) Blockade of T- and B-lymphocyte development by antibody to the yc subunit of the receptors for interleukins 2, 4, and 7. Proc. Natl. Acad. Sci. USA 92, 5689–5693.
von Freeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E., and Murray, R. (1995) Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519–1526.
Peschon, J. J., Morrissey, P. J., Grabstein, K. H., et al. (1994) Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955–1960.
Puel, A., Ziegler, S. F., Buckley, R. H., and Leonard, W. J. (1998) Defective IL7R expression in T(—)B(4-)NK(+) severe combined immunodeficiency. Nat. Genet. 20, 394–397.
Porter, B. O. and Malek, T. R. (1999) IL-2RbetaIIL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of yc—l— mice: roles for both IL-2 and IL-15 in CD8aa IEL development. J. Immunol. 163, 5906–5912.
Puck, J. M., Pepper, A. E., Henthorn, P. S., et al. (1997) Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 89, 1968–1977.
Puck, J. M. (1996) IL2RGbase: a database of yc-chain defects causing human X-SCID. Immunol. Today 17, 507–511.
Niemela, J. E., Puck, J. M., Fischer, R. E., Fleisher, T. A., and Hsu, A. P. (2000) Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency. Clin. Immunol. 95, 33–38.
Kumaki, S., Ishii, N., Minegishi, M., et al. (2000) Characterization of the gamma c chain among 27 unrelated Japanese patients with X-linked severe combined immunodeficiency (X-SCID). Hum. Genet. 107, 406–408.
Fugmann, S. D., Muller, S., Friedrich, W., Bartram, C. R., and Schwarz, K. (1998) Mutations in the gene for the common y chain (yc) in X-linked severe combined immunodeficiency. Hum. Genet. 103, 730–731.
Clark, P. A., Lester, T., Genet, S., et al. (1995) Screening for mutations causing X-linked severe combined immunodeficiency in the IL-2R y chain gene by single-strand conformation polymorphism analysis. Hum. Genet. 96, 427–432.
Markiewicz, S., Subtil, A., Dautry-Varsat, A., Fischer, A., and de Saint Basile, G. (1994) Detection of three nonsense mutations and one missense mutation in the interleukin-2 receptor y chain gene in SCIDX1 that differently affect the mRNA processing. Genomics 21, 291–293.
DiSanto, J. P., Dautry-Varsat, A., Certain, S., Fischer, A., and de Saint Basile, G. (1994) Interleukin-2 (IL-2) receptor y chain mutations in X-linked severe combined immunodeficiency disease result in the loss of high-affinity IL-2 receptor binding. Eur. J. Immunol. 24, 475–479.
Ishii, N., Asao, H., Kimura, Y., et al. (1994) Impairment of ligand binding and growth signaling of mutant IL-2 receptor y-chains in patients with X-linked severe combined immunodeficiency. J. Immunol. 153, 1310–1317.
Kanai, N., Yanai, F., Hirose, S., et al. (1999) A G to A transition at the last nucleotide of exon 6 of the yc gene (868G-A) may result in either a splice or missense mutation in patients with X-linked severe combined immunodeficiency. Hum. Genet. 104, 36–42.
Kumaki, S., Ochs, H. D., Kuropatwinski, K. K., et al. (1999) A novel mutant yc chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action. Clin. Exp. Immunol. 115, 356–361.
Schmalstieg, F. C., Leonard, W. J., Noguchi, M., et al. (1995) Missense mutation in exon 7 of the common y chain gene causes a moderate form of X-linked combined immunodeficiency. J. Clin. Invest. 95, 1169–1173.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Olosz, F., Malek, T.R. (2003). Molecular Basis for Binding Multiple Cytokines by γc. In: Fantuzzi, G. (eds) Cytokine Knockouts. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-405-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-405-4_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-415-9
Online ISBN: 978-1-59259-405-4
eBook Packages: Springer Book Archive